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Periodontitis Prevalence and Severity
in Indonesians With Type 2 Diabetes
Hendri Susanto,* Willem Nesse,† Pieter U. Dijkstra,‡ Dewi Agustina,* Arjan Vissink,†
and Frank Abbas§i
Background: The prevalence of diabetes mellitus type 2
(DM2) in Indonesia is high and still rising. Periodontitis is asso-
ciated with DM2. No study has investigated this association in
Indonesia, nor has any study investigated this association us-
ing a variety of methods to operationalize periodontitis. The
present study compares prevalence and severity of periodon-
titis in patients with DM2 to healthy controls, using different
methods to operationalize periodontitis.
Methods: A total of 78 subjects with DM2 and 65 healthy
control subjects underwent a full-mouth periodontal screening
assessing probing depth, gingival recession, plaque index,
and bleeding on probing. Using these measurements, the
prevalence and severity of periodontitis was operationalized
in various ways. Differences in the prevalence and severity
of periodontitis between subjects with DM2 and healthy sub-
jects were analyzed using univariate analyses. In regression
analyses, the prevalence and severity of periodontitis were pre-
dicted on the basis of DM2 presence, controlling for con-
founders and effect modification.
Results:Prevalence of periodontitis was significantly higher
in subjects with DM2 compared to healthy subjects, showing
odds ratios of 5.0 and 6.1. Likewise, periodontitis severity
was significantly higher in subjects with DM2.
Conclusion: Indonesian subjects with DM2 had more prev-
alent and more severe periodontitis than healthy Indonesian
subjects, independent of confounding factors or the methods
used to operationalize periodontitis. J Periodontol 2011;
82:550-557.
KEY WORDS
Diabetes mellitus; periodontal inflamed surface area;
periodontitis.
D
iabetes mellitus (DM) is a chronic
disease characterized by dysre-
gulation of carbohydrate, pro-
tein, and lipid metabolism. An elevation
of blood glucose level (hyperglycemia)
is the primary feature of DM and results
from a defect in insulin secretion by
pancreatic b cells, a decrease in insulin
sensitivity, or a combination of both. The
most common form of DM is DM type
2 (DM2), which accounts for 85% of all
diabetes patients.1 The estimated world-
wide prevalence of DM is 220.5 million,
or 2.8% of the world’s population. DM
currently is the twelfth leading cause of
death in the world. The prevalence is
estimated to rise up to 4.4%, putting DM
in the top 10 leading causes of death
by 2030.2,3 With the increasing preva-
lence of DM, this already vast and world-
wide epidemic will increasingly pose
serious problems to public health. These
problems mostly arise from the compli-
cations associated with DM, such as
myocardial infarction, cerebrovascular
disease, retinopathy, nephropathy, and
neuropathy.4
Periodontitis is more prevalent and
severe among patients with DM2 than
among healthy controls.5-7 Thus, DM2
may initiate or deteriorate periodontitis.
However, the reverse could also be true:
periodontitis may initiate or deteriorate
DM2. The strongest support for this
comes from studies showing that treat-
ment of periodontitis improves glyc-
emic control in DM2 patients.8-13 Thus,
there is an association between DM2
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and periodontitis that seems to be bilaterally causal
in nature (i.e., one causes or deteriorates the other
and vice versa).
The strength of associations between periodon-
titis; and DM2 seems to differ geographically. Stud-
ies performed among different ethnic groups show
different associations between periodontitis and
DM2.5,14-17 These differences in the strength of as-
sociations may, apart from differences in study de-
sign and data analysis, be based on genetic, dietary,
cultural, and other differences among ethnic groups.18
Therefore, findings among one ethnic population
cannot automatically be generalized to another eth-
nic population.
South East Asia hosts approximately 10% of the
world’s current population. With 240 million inhabi-
tants, Indonesia is the fourth most populous country
in the world. The prevalence of DM in South East Asia
is 5.3%.19 In Indonesia, the prevalence of DM in 2008
was 5.7%,20 putting Indonesia in the top 10 countries
with the most DM patients in the world. By the year
2030, the estimated number of patients with DM in
Indonesia will be >20 million (10% of the popula-
tion).2 With this high and rising prevalence of DM2
in Indonesia, periodontitis prevalence and severity
may also rise. Only three studies report on the as-
sociation between periodontitis and DM2 in South
East Asia: Thailand,21 Singapore,22 and Indonesia.23
Unfortunately, in the latter study, the way in which peri-
odontitis was measured and defined is unclear. This
study did not make a distinction between patients with
DM1 and DM2, leaving many questions unanswered.
Also remaining unanswered is the influence of
using a particular method to operationalize peri-
odontitis on the strength of an association between
periodontitis and DM2. The use of different methods
to operationalize periodontitis prevalence and se-
verity may influence not only the strength of the asso-
ciations between a given disease and periodontitis,
but may even influence whether an association is ob-
served at all. For example, in research linking peri-
odontitis to preterm low birth weight, 13 different
methods have been used to operationalize periodon-
titis. Depending on the method used, either an asso-
ciation24,25 or no association26 between periodontitis
and preterm low birth weight was observed. The same
may be true for periodontitis and DM2.
The present study assesses prevalence and sever-
ity of periodontitis among DM2 patients in Indonesia,
using multiple, commonly used methods to opera-
tionalize both periodontitis prevalence and severity.
MATERIALS AND METHODS
Subjects
DM2 patients were recruited at three different sites in
Yogjakarta, Indonesia: 1) Internal Medicine Depart-
ment of the Dr. Sardjito Hospital: 2) Prof. Soedomo
Oral and Dental Hospital, Faculty of Dentistry,
Gadjah Mada University; and 3) Diabetes Center of
Jogjakarta International Hospital. DM2 patients were
diagnosed according to World Health Organization
criteria: fasting blood glucose level ‡126 mg/dl or
a postprandial blood glucose level ‡200 mg/dl.27
Healthy controls were recruited in Prof. Soedomo
Oral and Dental Hospital Gadjah Mada University. In-
clusion criteria for all subjects were ‡18 years of age
and with ‡8 teeth. This study was approved by the
Ethical Committee for Research of the Medical Fac-
ulty of Gadjah Mada University, and was conducted
from July 2008 to February 2009.
To assess whether periodontitis prevalence and
severity differed between DM2 patients and healthy
controls, 78 DM2 patients (35 males and 43 females)
and 65 healthy controls (22 males and 43 females),
who gave oral informed consent, underwent a full-
mouth periodontal examination. Full-mouth periodon-
tal probing depth (PD), gingival recession, plaque
score, and bleeding on probing (BOP) measurements
were performed on all teeth, six sites per tooth. All
permanent fully erupted teeth were examined with
a manual periodontal color-coded standard probe.¶
Measurements were made in millimeters and were
rounded to the nearest whole millimeter. Clinical at-
tachment loss (AL) was defined as the distance from
the cemento-enamel junction to the bottom of the
pocket/sulcus, and calculated as the mathematical
sum of the PD and gingival recession measure-
ments.28 BOP was recorded as either present or ab-
sent within 30 seconds after probing at six sites per
tooth. The number of missing teeth was also recorded.
Plaque was defined as being present or absent at six
points on each tooth.29
Periodontitis prevalence, extent, and severity were
operationalized using a variety of methods, all of
which are currently used to study the association be-
tween periodontitis and other diseases. All methods
were calculated using conventional clinical mea-
surements obtained during the periodontal examina-
tion. Periodontitis prevalence was operationalized
by using two diagnostic threshold values: having one
site with PD ‡4 mm and clinical AL ‡3 mm,26 and
having one site with PD ‡5 mm and clinical AL
‡2 mm.30 The following methods to operationalize
periodontitis extent and severity were calculated us-
ing an online spreadsheet:# the number of sites with
PD ‡4, ‡5, and ‡6 mm; the numbers of sites with clin-
ical AL‡3,‡4,‡5, and‡6 mm; mean PD; mean clinical
AL; and the percentage of sites with BOP.26
¶ DENTSPLY, London, UK.
# Microsoft Excel 2003 spreadsheet for Windows, Microsoft, Redmond,
WA.
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Additionally, two recently introduced measures of
periodontitis severity, the periodontal epithelial sur-
face area (PESA) and the periodontal inflamed sur-
face area (PISA),31 were both calculated using the
downloadable spreadsheet.** PESA reflects the sur-
face area of all pocket epithelium in square milli-
meters, whereas PISA reflects the surface area of
bleeding pocket epithelium in square millimeters.
PESA and PISA are calculated using conventional clin-
ical AL, gingival recession, and BOP measurements.
PISA quantifies the amount of inflamed periodontal
tissue and it is suggested that PISA thereby quantifies
the inflammatory burden posed by periodontitis.
All participants completed a validated general
health assessment questionnaire32-34 to identify other
medical conditions that might be a risk factor for peri-
odontitis. The original questionnaire was translated
from English into Indonesian; a reverse translation to
English was made to check for potential differences.
No substantial differences were found. Additionally,
ethnicity,35 body mass index (BMI),36 dental plaque,
age, sex, smoking (pack-years), and socioeconomic
status (SES) (operationalizedusing level of education)
were recorded for each participant (Table 1), because
these are potential determinants of periodontitis.37
To ensure that healthy controls were not undiag-
nosed patients with diabetes, all participants under-
went venipuncture. Blood glucose and glycated
hemoglobin (HbA1c) were determined for both DM2
patients and healthy controls. Controls with a blood
HbA1c level of ‡6.5% were excluded from the analy-
sis, to exclude latent DM2 status.
Statistical Analyses
Differences in periodontitis prevalence, extent, and
severity between DM2 patients and healthy subjects
were analyzed first using univariate analyses (indepen-
dent sample t test or x2 test as appropriate). Likewise,
differences in potential predictors of periodontitis
(age, sex, BMI, SES, smoking, plaque score, number
of teeth, ethnicity, and other medical conditions) be-
tween DM2 patients and healthy controls were tested
for significance using univariate analyses. In case
Table 1.
Characteristics of Healthy Controls and Subjects With DM2 and Potential Determinants
of Periodontitis Severity
Patient Characteristics Controls (n = 65) DM2 (n = 78)
Difference
(95% confidence interval) P Value
Age: mean (SD) years 50.5 (10.6) 56.7 (9.4) 6.2 (2.8 to 9.5) <0.00*
Sex: n (%) 0.180†
Male 22 (34) 35 (45)
Female 43 (66) 43 (55)
Smoking: n (%) 10 (15) 14 (18) 0.683†
Java origin: n (%) 60 (92) 73 (94) 0.765†
Education: n (%) 0.762†
Low 17 (26) 18 (23)
Middle 26 (40) 29 (37)
High 22 (34) 31 (40)
BMI (SD) (kg/m2) 24.6 (3.9) 25.1 (3.8) 0.460‡
Number of teeth (SD) (n) 24.5 (5.5) 22.9 (6.1) 0.112‡
Plaque score (SD) (%) 92.5 (9.2) 90.8 (7.6) 0.211‡
Medical conditions: n (%)‡
Hypertension 12 (18) 26 (33) 15% (0.3 to 29) <0.05*§
Gastritis 4 (6) 10 (13) 0.182§
Anemia 2 (3) 0 (0) 0.119§
Angina Pectoris 0 (0) 3 (4) 0.110§
Education: low, elementary and junior school; middle, high school; high, university.
* Statistically significant difference (P £0.05) between DM2 and controls.
† x2 test.
‡ Independent samples t test.
§ Only diseases with a prevalence of at least 1% (i.e., two patients) were analyzed.
** Microsoft Excel 2003 spreadsheet for Windows, Microsoft.
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periodontitis prevalence, extent, and severity and
any of the potential predictors of periodontitis dif-
fered significantly between DM2 patients and healthy
controls, the predictors of periodontitis other than
DM2 might act as confounders or effect modifiers.
Because periodontitis severity was operationalized
as several interval variables (PISA, or number of sites
with PD ‡4 mm), linear regression analyses (Table
4) (backward stepwise) were performed to predict
extent and severity of periodontitis on the basis of
DM2 presence and the other potential predictors
(age, sex, BMI, SES, smoking, plaque score, number
of teeth, ethnicity, and other medical conditions).
To facilitate clinical interpretation of presented an-
alyses, age was centered to its mean (53.86). Be-
cause periodontitis prevalence was operationalized
as two dichotomous variables, logistic regression
analyses were performed in a similar way. Odds ratios
and 95% confidence intervals were calculated using
these logistic regression analyses. Interaction among
different predictors of periodontitis was explored. Sta-
tistics were calculated using a software program.††
RESULTS
Of the original 76 healthy controls, 11 subjects were
excluded because of HbA1c levels >6.5%, leaving 65
healthy controls and 78 DM2 patients (Table 1).
The prevalence of periodontitis in DM2 subjects was
significantly higher than healthy controls, regardless
of the definition used (Table 2). The extent and se-
verity of periodontitis was also significantly higher in
participants with DM2 compared to controls, again in-
dependent of the method used to operationalize peri-
odontitis severity (Table 3).
Table 2.













PD4&AL3 (yes) 46 (71%) 72 (92%) 21% (9% to 32%) 5 (1.8 to 13.3) 0.001*†
PD5&AL2 (yes) 20 (31%) 57 (73%) 42% (26% to 55%) 6.1 (2.9 to 12.6) <0.001*†
OR: Odds ratios were calculated using binary logistic regression analyses controlling for confounders.
PD4&AL3 = participants with one site exhibiting both PD 4 mm and clinical AL 3 mm; PD5&AL2 = participants with one site exhibiting both PD 5 mm and
clinical AL 2 mm.
* Statistically significant difference (P £0.05) between DM2 and controls.
† x2 test.
Table 3.
Differences in Periodontitis Severity Between Healthy Controls and Subjects With DM2
Periodontitis Severity
Controls (n = 65) Mean
(SD)
DM2 (n = 78) Mean
(SD)
Difference (95%
confidence interval) P Value
PESA (mm2) 863 (259.4) 1,190.5 (1161.5) 327.5 (58.3 to 596.6) 0.018*
PISA (mm2) 154.1 (192.1) 429.4 (964.9) 275.3 (52.9 to 497.6) 0.016*
Number of sites with
Clinical AL ‡3 mm 35.8 (23.1) 63.5 (29.9) 27.6 (18.8 to 36.4) <0.001*
Clinical AL ‡4 mm 12.3 (15.1) 37.1 (27.2) 24.8 (17.7 to 31.9) <0.001*
Clinical AL ‡5 mm 5.9 (10.2) 22.9 (21.4) 16.9 (11.5 to 22.4) <0.001*
Clinical AL ‡6 mm 3.1 (7.3) 13.7 (16.2) 10.6 (6.6 to 14.7) <0.001*
PD ‡4 mm 4.5 (7.9) 16.6 (21.2) 12.1 (6.9 to 17.3) <0.001*
PD ‡5 mm 1.4 (3.7) 7.7 (12.5) 6.3 (3.4 to 9.2) <0.001*
PD ‡6 mm 0.8 (2.3) 4.5 (9.3) 3.7 (1.5 to 5.9) 0.001*
BOP (%) 14.2 (13.3) 24.9 (16.1) 10.7 (5.8 to 15.5) <0.001*
Clinical AL mean (mm) 2.2 (0.9) 3.1 (1.3) 0.9 (0.5 to 1.3) <0.001*
PD mean (mm) 1.8 (0.4) 2.2 (0.6) 0.4 (0.2 to 0.5) <0.001*
* Statistically significant difference (P £0.05) between DM2 and controls.
†† SPSS 16.0, IBM, Chicago, IL.
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Table 4.
DM2 and Age as Statistical Predictors of Periodontitis Extent and Severity: Results
of Multiple Linear Regression Analyses With Periodontitis Operationalized According












DM2 327.49 0.18 <0.05 36.65 to 618.33
Constant 863.04 <0.001 648.25 to 1077.84
PISA 0.04
DM2 275.29 0.19 <0.05 34.69 to 515.89
Constant 154.06 0.089 -23.63 to 331.76
BOP % 0.11
DM2 10.65 0.34 <0.001 5.71 to 15.60
Constant 14.23 <0.001 10.58 to 17.89
PD ‡4 mm† 0.12
DM2 12.10 0.34 <0.001 6.60 to 17.60
Constant 4.92 <0.05 0.43 to 8.56
PD ‡5 mm† 0.10
DM2 6.30 0.31 <0.001 3.13 to 9.47
Constant 1.35 0.254 -0.98 to 3.69
PD ‡6 mm† 0.07
DM2 3.70 0.26 0.002 1.36 to 6.03
Constant 0.75 0.388 -0.97 to 2.47
PD mean 0.11
DM2 0.37 0.33 <0.001 0.19 to 0.54
Constant 1.83 <0.001 1.70 to 1.96
Clinical AL ‡3 mm† 0.24
DM2 24.25 0.40 <0.001 14.99 to 33.49
Age centered 0.54 0.19 0.017 0.10 to 0.98
Constant 37.7 <0.001 31.0 to 44.4
Clinical AL ‡4 mm† 0.29
DM2 20.85 0.41 <0.001 13.31 to 28.40
Age centered 0.64 0.26 0.001 0.28 to 1.00
Constant 14.5 <0.001 9.0 to 19.9
Clinical AL ‡5 mm† 0.25
DM2 14.12 0.37 <0.001 8.31 to 19.94
Age centered 0.46 0.25 0.002 0.18 to 0.74
Constant 7.5 0.001 3.26 to 11.68
Clinical AL ‡6 mm† 0.19
DM2 8.82 0.32 <0.001 4.42 to 13.22
Age centered 0.29 0.22 0.008 0.08 to 0.50
Constant 4.03 0.013 0.85 to 7.22
Clinical AL mean† 0.21
DM2 0.71 0.29 <0.001 0.33 to 1.09
Age centered 0.03 0.27 0.001 0.01 to 0.05
Constant 2.27 <0.001 2.00 to 2.54
Age-centered = age minus mean age; constant = sites with PD ‡4 mm that are not dependent on DM2 presence or increasing age; b = unstandardized
coefficient; number of sites with clinical AL = clinical attachment loss ‡3, ‡4, ‡5, and ‡6 mm; number of sites with PD = probing depth ‡4, ‡5, and ‡6 mm.
* P value of £0.05 was considered statistically significant.
† Number of sites.
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Age and hypertension were the only potential pre-
dictors of periodontitis prevalence and severity that
differed significantly between DM2 and healthy sub-
jects in the univariate analysis (Table 1). In the multi-
ple linear regression analyses, controlling for age
and hypertension as potential confounders, DM2 re-
mained a significant predictor of all measures of peri-
odontitis severity (Table 4). Age was an additional
predictor of periodontitis severity, together with DM2,
whenever periodontitis severity was operationalized
using AL. Age did not modify the effect of DM2 on
periodontitis severity. Hypertension was not a pre-
dictor of periodontitis prevalence or severity.
DISCUSSION
This study reveals that Indonesian subjects with DM2
had significantly increased prevalence, extent, and
severity of periodontitis compared to healthy Indo-
nesian subjects. Moreover, these increases were in-
dependent of the methods used to operationalize
periodontitis. Furthermore, these increases seemed
to be independent of confounding factors, i.e., age,
sex, smoking, BMI, ethnicity, SES, and other medical
conditions.
Age was an additional predictor of all methods
that used clinical AL to operationalize periodontitis
severity. This could have been expected because clin-
ical AL reflects the accumulation of damage sus-
tained by the periodontium over time. In other
words, with increasing age, clinical AL increases.
Nevertheless, DM2 remained a significant predictor
of every method used to operationalize periodontitis
prevalence and severity.
Before the study we did not perform a formal
sample-size calculation, although this study is the
second on periodontitis and DM2 in Indonesia. It
is not clear how periodontitis was measured and de-
fined in the first study, and no distinction was made
among patients with DM1 and DM2.23 In a post hoc
power analysis it seemed that we had a power of
0.92 to find a difference in prevalence of periodon-
titis of 21% between controls (n = 65; prevalence =
71%) and DM2 patients (n = 78; prevalence = 91%).
A sample of 50 DM2 patients and 50 controls would
have been enough to detect this difference (power,
0.80).
A limitation of this study is that we did not use
a population-based sampling scheme to select DM2
patients. However, Indonesian patients with DM2
regularly visit hospitals to make use of the laboratory
facilities. Thus, selection of DM2 patients at the two
internal medicine hospitals does not mean a subset
of patients with more severe DM2 patients was se-
lected. Rather, these subjects may be thought to rep-
resent a sample of diagnosed and treated Indonesian
patients with DM2. However, true DM2-associated
increased periodontitis risk may be underestimated,
because a substantial portion of patients with DM2
often goes undiagnosed. Likely, these patients have
worse blood sugar control and consequently worse peri-
odontal status. On the other hand, the DM2 patients
that were recruited from a dental hospital may have
visited this hospital for periodontitis, overestimating
DM2-associated periodontitis prevalence in this sub-
group. Likewise, because controls were all selected
from the same dental hospital, the prevalence of peri-
odontitis in controls may also have been overesti-
mated. Because the prevalence in both groups might
beoverestimated, the overall effect on calculated DM2-
associated periodontitis risk may have been small.
Finally, selection of healthy controls at a dental hos-
pital may not be representative of the general In-
donesian population without DM2. Thus, although
some threats to the generalizability of our results re-
main, the increased DM2-associated periodontitis
risk does seem to have sufficient generalizability
and might sooner have been underestimated rather
than overestimated.
The finding that DM2 subjects have an increased
prevalence and severity of periodontitis is in accor-
dance with other studies.30,38,39 A major achieve-
ment of the present study is that a large variety of
methods to operationalize periodontitis prevalence
and severity has been applied, and that the conclu-
sions that could be drawn from the results were irre-
spective of the measures used. This indicates that
this association is robust. Because the prevalence
of DM2 in Indonesia20 and South East Asia19 is al-
ready high and is predicted to rise further, the preva-
lence and severity of periodontitis may also rise.
Because of the vast number of people living in In-
donesia and South East Asia and the proposed bilat-
eral association between DM2 and periodontitis, this
will increasingly pose serious problems to public
health.
Two main mechanisms are thought to underlie
the proposed bilateral association between DM2
and periodontitis. One underlying mechanism is that
DM2 may alter local immune responses within
periodontal tissue. DM2 may result in small vessel
damage within the periodontium, resulting in poor
nutrient delivery, decreased oxygen diffusion, and de-
creased elimination of metabolic waste products.40
Furthermore, hyperglycemia alters collagen metab-
olism, which predisposes to impaired wound healing.
In general, hyperglycemia results in the formation of
proteins known as advanced glycation end products
(AGEs). AGEs may be associated with a state of en-
hanced oxidative stress, thereby accelerating tis-
sue injury. AGEs also function as a chemotactic for
monocytes, thereby magnifying the inflammatory
response, delaying wound healing and tissue repair
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and inducing connective-tissue damage and bone
resorption. Finally, hyperglycemia and the imbalance
in lipid metabolism impair neutrophil and monocyte
functioning.41-44 All of these factors may contribute
to DM2 predisposing to periodontitis.
The second underlying mechanism of the asso-
ciation between DM2 and periodontitis is that peri-
odontitis may play a role in initiating or exacerbating
DM2.7,43,45 Periodontitis poses an inflammatory bur-
den consisting of increased serum levels of inflam-
matory mediators, such as C-reactive protein and
interleukin-6.46 This inflammatory burden in turn
leads to deteriorating blood glucose control in DM2
patients.43 The higher the amount of inflamed peri-
odontal tissue, the higher the inflammatory burden,
and the poorer blood glucose control in DM2 pa-
tients may be thought to be.
PISA quantifies the amount of inflamed periodontal
tissue (representing it as the surface area of inflamed
periodontal epithelium in square millimeters), and it
is suggested that PISA thereby quantifies the inflam-
matory burden posed by periodontitis.31 It was shown
that there is indeed a dose relationship between
PISA and HbA1c in patients with DM2 in the Dutch
Caribbean.47 Likewise, the finding of a significantly
higher PISA among DM2 subjects in the present
study may mean that periodontitis is a risk factor for
poor glucose control. Treating periodontitis might
improve blood glucose control,8-13 and prevention
and treatment of periodontitis in patients with DM2
might contribute to better general health in patients
with DM2.48,49
CONCLUSIONS
This study shows that periodontitis prevalence is
significantly higher in a group of Indonesian patients
with DM2 compared to a group of healthy Indone-
sians. Furthermore, Indonesian subjects with DM2
have more extended and more severe periodontitis
than healthy Indonesian subjects. Given the already
high and increasing prevalence of DM2 in Indone-
sia, patients with DM2 should be screened for peri-
odontitis and preventive oral health care should
become part of the regular care provided to Indone-
sian patients with DM2. Given the proposed bilateral
association between DM2 and periodontitis, such
care may contribute to better oral and overall health.
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